Results 111 to 120 of about 609,595 (394)

Biomarkers in Cervical Cancer Screening [PDF]

Disease Markers, 2007
In industrialized countries, population wide cytological screening programs using the Pap test have led to a substantial reduction of the incidence of cervical cancer. Despite this evident success, screening programs that rely on Pap‐stained cytological samples have several limitations.
Magnus von Knebel Doeberitz, Nicolas Wentzensen   +1 more
openaire   +2 more sources

Preparation and characterization of renal cell peptides from fetal rats for their antitumor activity

FEBS Open Bio, EarlyView.
This study aimed to prepare renal cells (RCs) from fetal rats which were digested by enzymes. Candidate peptides RCPs were characterized by capillary HPLC and MS and their bioactivity was predicted using peptideranker. The predicted top 10 bioactive peptides were synthesized.
Zhe Zhang, Yuan Cao, Jing Du, Ying Zhang, Junxia Wang, Ying Yuan, Lianqing Sun   +6 more
wiley   +1 more source

Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England. [PDF]

, 2017
Background: Cervical cancer incidence has decreased over time in England particularly after the introduction of organized screening. In Portugal, where opportunistic screening has been widely available with only slightly lower coverage than that of the ...
Baguelin, Marc, Jit, Mark, Mendes, Diana, Mesher, David, Pista, Angela   +4 more
core   +1 more source

Evaluation of the burden of HPV-related hospitalizations as a useful tool to increase awareness: 2007–2017 data from the sicilian hospital discharge records [PDF]

, 2020
In light of the implementation of human papillomavirus (HPV) prevention strategies, epidemiological studies in different geographical areas are required in order to assess the impact of HPV-related diseases.
Amato L., Amodio E., Candiloro S., Casuccio A., Costantino C., Maranto M., Marrella A., Palmeri S., Pizzo S., Restivo V., Vitale F.   +10 more
core   +1 more source

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

JAMA Internal Medicine, 2019
Key Points Question What are efficient approaches for triage of human papillomavirus–positive women in cervical cancer screening? Findings This cohort study of 3225 women found that p16/Ki-67 dual stain, alone or in combination with human papillomavirus ...
N. Wentzensen, M. Clarke, R. Bremer, Nancy E. Poitras, D. Tokugawa, Patricia E Goldhoff, P. Castle, M. Schiffman, Julie D Kingery, Kiranjit Grewal, Alexander Locke, W. Kinney, T. Lorey   +12 more
semanticscholar   +1 more source

Cervical Spinal Cord Magnetization Transfer Ratio and Its Relationship With Clinical Outcomes in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The cervical spinal cord (cSC) is highly relevant to clinical dysfunction in multiple sclerosis (MS) but remains understudied using quantitative magnetic resonance imaging (MRI). We assessed magnetization transfer ratio (MTR), a semi‐quantitative MRI measure sensitive to MS‐related tissue microstructural changes, in the cSC and its ...
Lisa Eunyoung Lee, Julien Cohen‐Adad, Irene M. Vavasour, Melanie Guenette, Katherine Sawicka, Neda Rashidi‐Ranjbar, Nathan Churchill, Akash Chopra, Adelia Adelia, Pierre‐Louis Benveniste, Anthony Traboulsee, Nathalie Arbour, Fabrizio Giuliani, Larry D. Lynd, Scott B. Patten, Alexandre Prat, Alice Schabas, Penelope Smyth, Roger Tam, Yunyan Zhang, Simon J. Graham, Mojgan Hodaie, Anthony Feinstein, Shannon Kolind, Tom A. Schweizer, Jiwon Oh, CanProCo Study Group   +26 more
wiley   +1 more source

Recommendations for a national agenda to substantially reduce cervical cancer [PDF]

, 2013
PURPOSE: Prophylactic human papillomavirus (HPV) vaccines and new HPV screening tests, combined with traditional Pap test screening, provide an unprecedented opportunity to greatly reduce cervical cancer in the USA.
Alexander, Kenneth, Brewer, Noel T., Casey, Baretta R., Chernofsky, Mildred R., Crosby, Richard, Derting, Libby, Devlin, Leah, Dunton, Charles J., Engle, Jeffrey, Fernandez, Maria, Fouad, Mona, Huh, Warner, Kinney, Walter, Pierce, Jennifer, Rios, Elena, Rothholz, Mitchel C., Saslow, Debbie, Shedd-Steele, Rivienne, Shlay, Judith C., Smith, Jennifer S., Vernon, Sally W., Walker, Joan, Wynn, Theresa, Zimet, Gregory D.   +23 more
core   +2 more sources

Barriers and facilitators to uptake of cervical cancer screening among women in Uganda: a systematic review

BMC Women's Health, 2019
BackgroundUganda has one of the highest age-standardized incidence rates of cervical cancer in the world. The proportion of Ugandan women screened for cervical cancer is low.
Eleanor Black, F. Hyslop, R. Richmond
semanticscholar   +1 more source

In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock, Jihyun Park, Dae‐Gyu Jang, Bangyao Zhao, Samuel J. Teener, Ian F. Webber‐Davis, Lili Zhao, Eva L. Feldman, Stephen A. Goutman   +8 more
wiley   +1 more source

The Implications of Insurance Status on Presentation, Surgical Management and Mortality among Non-Metastatic Breast Cancer Patients in Indiana [PDF]

, 2018
Background The National Breast and Cervical Cancer Early Detection Program seeks to reduce health care disparities by providing uninsured and underinsured women access to screening mammograms.
Fisher, Carla S., Haggstrom, David A., Ludwig, Kandice K., Miller, Kathy D., Obeng-Gyasi, Samilia, Timsina, Lava   +5 more
core   +1 more source